Wilmington, Delaware, United States, March 21, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global antiplatelet drugs market size was valued USD 2.1 Bn in 2022 and it is ...
An analysis of data from previously published studies indicates that use of the antiplatelet drug clopidogrel for patients who have common genetic variants of a certain gene and are undergoing a ...
Researchers at the University of Illinois at Chicago have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet ...
Patients who received a single antiplatelet drug therapy— usually aspirin — after transcatheter aortic valve replacement (TAVR) had about half the risk of dying in the subsequent 6 months compared ...
SHANGHAI, June 20, 2026 /PRNewswire/ -- CureGene Pharmaceutical today announced that the first participant has been successfully dosed in the U.S. pivotal clinical trial of Evategrel (CG-0255), its ...
A new antiplatelet drug with a completely novel mechanism of action may hold the promise of delivering the holy grail ― reducing cardiac events without increasing bleeding. That is the hope behind the ...
The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to be used to lessen the side effects of blood-thinning drugs for patients ...
Professor, University of Georgia, Athens, Ga. Current American College of Cardiology guidelines recommend dual antiplatelet therapy following drug-eluting stent placement for at least 12 months (J Am ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results